title: The V617F JAK2 mutation is uncommon in cancers and in myeloid malignancies other than the classic myeloproliferative disorders.
authors.forename: Linda M
authors.initials: LM
authors.lastname: Scott
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Campbell
authors.forename: E Joanna
authors.initials: EJ
authors.lastname: Baxter
authors.forename: Tony
authors.initials: T
authors.lastname: Todd
authors.forename: Philip
authors.initials: P
authors.lastname: Stephens
authors.forename: Sarah
authors.initials: S
authors.lastname: Edkins
authors.forename: Richard
authors.initials: R
authors.lastname: Wooster
authors.forename: Michael R
authors.initials: MR
authors.lastname: Stratton
authors.forename: P Andrew
authors.initials: PA
authors.lastname: Futreal
authors.forename: Anthony R
authors.initials: AR
authors.lastname: Green
mesh_terms: D002478:Cells, Cultured; D005820:Genetic Testing; D006801:Humans; D053614:Janus Kinase 2; D009101:Multiple Myeloma / Q000201:enzymology* / Q000235:genetics*; D009154:Mutation / Q000235:genetics*; D009196:Myeloproliferative Disorders / Q000201:enzymology* / Q000235:genetics*; D011505:Protein-Tyrosine Kinases / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D014633:Valine / Q000235:genetics*
chemical_list: D011518:Proto-Oncogene Proteins; D011505:Protein-Tyrosine Kinases; C507924:JAK2 protein, human; D053614:Janus Kinase 2; D014633:Valine